Evolus, Inc.
USD7.13
-0.02 (-0.28%)
CEO
David Moatazedi
IPO Date
2018-02-08
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$7.15
Prev. Close
$7.15
Day Low
$6.96
Day High
$7.32
52W Low
$3.86
52W High
$10.20
Market Cap
$0.47B
Volume
2.08M
| 13,669 |
| $4.75 |
| 18 Mar 2026 | MOATAZEDI DAVID | director, officer: See Remarks | M-Exempt | Acquired | 67,489 | $0.00 |
| 18 Mar 2026 | MOATAZEDI DAVID | director, officer: See Remarks | S-Sale | Disposed | 116,720 | $4.89 |
| 18 Mar 2026 | MOATAZEDI DAVID | director, officer: See Remarks | M-Exempt | Disposed | 67,489 | $0.00 |
| 18 Mar 2026 | Avelar Rui | See Remarks | M-Exempt | Acquired | 8,804 | $0.00 |
| 18 Mar 2026 | Avelar Rui | See Remarks | S-Sale | Disposed | 29,996 | $4.89 |
| 18 Mar 2026 | Avelar Rui | See Remarks | M-Exempt | Disposed | 8,804 | $0.00 |
| 19 Feb 2026 | Parschauer Karah Herdman | director | A-Award | Acquired | 45,559 | $0.00 |
| 19 Feb 2026 | Stewart Brady | director | A-Award | Acquired | 45,559 | $0.00 |